Bristol-Myers Squibb Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Bristol-Myers Squibb (BMY) Tops Q2 EPS by 17c; Boosts FY15 EPS Outlook
July 23, 2015 7:31 AM EDTBristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $0.53, $0.17 better than the analyst estimate of $0.36. Revenue for the quarter came in at $4.16 billion versus the consensus estimate of $3.71 billion.
SECOND QUARTER BUSINESS DEVELOPMENT UPDATE
In... More